Phase 2 Clinical Trial Evidence That A Retinoid-X Receptor Agonist Promotes Remyelination In People With Relapsing-Remitting Multiple SclerosisJ. Brown, N. Cunniffe,F. Prados,B. Kanber,J. Jones,E. Needham, Z. Georgieva,D. Rog,O. Pearson, J. Overell,D. Macmanus,R. Samson,J. Stutters,C. Gandini Wheeler-Kingshott, A. Michell, P. Connick,R. Franklin,S. Chandran,D. Altmann, D. Chard,A. ColesMULTIPLE SCLEROSIS JOURNAL（2020）引用 2|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
